Does Rallies show Form 4 insider transactions for DNA?

Yes. Rallies tracks DNA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is DNA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for DNA. It does not provide personalized investment advice.

DNA (Ginkgo Bioworks Holdings, Inc.) Stock Analysis - Insider Trades

Ginkgo Bioworks Holdings, Inc. (DNA) is a publicly traded Healthcare sector company. As of May 20, 2026, DNA trades at $7.65 with a market cap of $481.44M and a P/E ratio of -1.42. DNA moved +4.76% today. Year to date, DNA is -12.97%; over the trailing twelve months it is -3.38%. Its 52-week range spans $5.00 to $17.58. Analyst consensus is sell with an average price target of $8.50. Rallies surfaces DNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading DNA stock inside the company?

Recent DNA insider activity includes Coen Steven P. sold 324, Coen Steven P. sold 33.17K, Canton Barry sold 124.73K, Shetty Reshma P. sold 124.73K, and Shetty Reshma P. sold 13.12K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

DNA Key Metrics

Key financial metrics for DNA
Metric	Value
Price	$7.65
Market Cap	$481.44M
P/E Ratio	-1.42
EPS	$-5.36
Dividend Yield	0.00%
52-Week High	$17.58
52-Week Low	$5.00
Volume	617.81K
Avg Volume	0
Revenue (TTM)	$141.31M
Net Income	$-304.39M
Gross Margin	0.00%

Recent DNA Insider Trades

Coen Steven P. sold 324 (~$2.58K) on Apr 17, 2026.
Coen Steven P. sold 33.17K (~$212.76K) on Apr 13, 2026.
Canton Barry sold 124.73K (~$802.49K) on Apr 10, 2026.
Shetty Reshma P. sold 124.73K (~$802.49K) on Apr 10, 2026.
Shetty Reshma P. sold 13.12K (~$83.90K) on Apr 9, 2026.

Latest DNA News

Ginkgo Bioworks Among Five in $58.76B Point-of-Care Diagnostics Market Growing 10% — May 12, 2026
Ginkgo Bioworks Q1 Revenue Plunges 49% to $19M, Plans to Double Nebula Lab — May 7, 2026
Ginkgo Bioworks Revives Extinct Plant Scents, Partners on Novel Perfumes — Mar 7, 2026
Ginkgo Bioworks Q4 Revenue Falls to $33M, Launches Cloud Lab and Sells Biosecurity — Mar 2, 2026
Ginkgo Bioworks Spins Off Biosecurity Unit, Doubles Autonomous Lab Racks to 100 — Feb 28, 2026

DNA Analyst Consensus

3 analysts cover DNA: 0 strong buy, 1 buy, 0 hold, 2 sell, 0 strong sell. Consensus rating is sell. Average price target: $8.50.

Common questions about DNA

Who is trading DNA stock inside the company?: Recent DNA insider activity includes Coen Steven P. sold 324, Coen Steven P. sold 33.17K, Canton Barry sold 124.73K, Shetty Reshma P. sold 124.73K, and Shetty Reshma P. sold 13.12K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for DNA?: Yes. Rallies tracks DNA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is DNA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for DNA. It does not provide personalized investment advice.